These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 710855)

  • 21. [Experimental studies of the pathomechanism of portal encephalopathy. I. Changes in monoamine oxidase (MAO) activity in the cerebral cortex and cerebellum of rats after portacaval shunt].
    Rokicki W; Rokicki M; Kamiński K; Peciak B; Gebska E
    Neuropatol Pol; 1989; 27(2):199-207. PubMed ID: 2626178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experimental hepatic encephalopathy. Study of the organization of a diurnal sleep pattern in rats with portocaval anastomosis].
    Beaubernard C; Salomon F; Bismuth H
    Biomedicine; 1980 May; 32(2):76-80. PubMed ID: 7190038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shunt.
    Zervos EE; Goode SE; Rosemurgy AS
    J Surg Res; 1998 Jan; 74(1):71-5. PubMed ID: 9536977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine metabolism in cirrhosis.
    Nordlinger BM; Fulenwider JT; Ivey GL; Faraj BA; Ali FM; Kutner M; Henderson JM; Rudman D
    J Lab Clin Med; 1979 Dec; 94(6):832-40. PubMed ID: 501206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ammonia on plasma and cerebrospinal fluid amino acids in dogs with and without portacaval anastomoses.
    Schäfer K; Ukida M; Steffen C; Bode C; Zelder O; Bode JC
    Res Exp Med (Berl); 1985; 185(1):35-44. PubMed ID: 2857496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats.
    Ribeiro J; Nordlinger B; Ballet F; Cynober L; Coudray-Lucas C; Baudrimont M; Legendre C; Delelo R; Panis Y
    Hepatology; 1992 Jan; 15(1):12-8. PubMed ID: 1727787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental studies of the pathomechanism of portal encephalopathy. II. Monoamine oxidase (MAO) activity in the rat brain after porta- caval shunt using 2 different methods].
    Rokicki M; Rokicki W; Tarnawski R; Gebska E; Peciak B
    Neuropatol Pol; 1989; 27(2):209-16. PubMed ID: 2696882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of amino acids in hepatic encephalopathy.
    Battistin L; Zanchin G
    Prog Clin Biol Res; 1980; 39():315-26. PubMed ID: 6105674
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantification of the capacity of the liver to remove ammonia from the circulation of dogs with portacaval transposition.
    Aldrete JS
    Surg Gynecol Obstet; 1975 Sep; 141(3):399-404. PubMed ID: 1162568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma amino acid patterns in hepatic encephalopathy of differing etiology.
    Rosen HM; Yoshimura N; Hodgman JM; Fischer JE
    Gastroenterology; 1977 Mar; 72(3):483-7. PubMed ID: 832796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of shunt occlusion following portosystemic decompression.
    Mehigan DG; Zuidema GD; Cameron JL
    Surg Gynecol Obstet; 1980 May; 150(5):661-3. PubMed ID: 7368049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between plasma free fatty acids and experimentally induced hepatic encephalopathy in the rat.
    Smit JJ; Bosman DK; Jörning GG; de Haan JG; Maas MA; Chamuleau RA
    Clin Chim Acta; 1991 Mar; 197(2):95-104. PubMed ID: 2049860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrojejunostomy inhibits postshunt siderosis.
    Doberneck RC; Fischer R; Smith D
    Surgery; 1975 Sep; 78(3):334-8. PubMed ID: 1154274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodialysis against activated charcoal suspension as a treatment of hepatic encephalopathy.
    Merino GE; Jetzer T; Buselmeier TJ; Najarian JS
    Trans Am Soc Artif Intern Organs; 1977; 23():591-8. PubMed ID: 910387
    [No Abstract]   [Full Text] [Related]  

  • 36. Decarboxylation to tyramine: a major route of tyrosine metabolism in mammals.
    David JC; Dairman W; Udenfriend S
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1771-5. PubMed ID: 4525291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: effects of systemic ammonium acetate and L-tryptophan.
    Bergqvist PB; Carpenedo R; Apelqvist G; Moroni F; Bengtsson F
    Pharmacol Toxicol; 1999 Sep; 85(3):138-43. PubMed ID: 10522754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin, glucagon, portal systemic shunting, and hepatic failure in the dog.
    Soeters PB; Weir G; Ebeid AM; Fischer JE
    J Surg Res; 1977 Sep; 23(3):183-8. PubMed ID: 886853
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic refractory encephalopathy. Evaluation of an ileostomy 22 years after portacaval shunt.
    Willson RA
    Dig Dis Sci; 1981 Sep; 26(9):839-42. PubMed ID: 7285749
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ameliorating effect of lactitol on experimental hepatic encephalopathy in Eck fistula dogs].
    Watanabe M; Ozaki T; Mushiroi T; Ukai Y; Ueda F; Kimura K; Katoh M; Matsumoto A; Kotani E; Itoh S
    Nihon Yakurigaku Zasshi; 1995 May; 105(5):403-13. PubMed ID: 7628788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.